therapeutic and prophylactic effectiveness of topical immunomodulator in treatment of acute respiratory infections
Clicks: 201
ID: 161560
2011
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
30.0
/100
200 views
15 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Clinical effectiveness and safety of topical immunomodulator IRS 19 in treatment and prophylaxis of infectious diseases of airways in adults and children was studied in numerous Russian clinical studies. The article reviews the most interesting results of these studies. Administration of bacterial lysates mixture lowers the rate of acute respiratory infections (ARI) and exacerbations of chronic ENT diseases in patients including frequently ailing children. Treatment with the drug results in much smoother disease’s course. Action of a drug shortens terms of a disease, induces significant decrease of ARI complications rate, normalization of nasopharinx biocenose, and lowers the need in antibacterial drugs.
| Reference Key |
shamsheva2011voprosytherapeutic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;O. V. Shamsheva;N. N. Zvereva |
| Journal | Biocontrol science |
| Year | 2011 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.